William Taranto spoke about his near decade at Merck Global Health Innovation Fund and how corporate venturing has evolved in that time.
William Taranto, president of pharmaceutical firm Merck & Co’s Global Health Innovation Fund (GHI), shared tips on how to build a resilient corporate venturing unit with Heidi Mason, co-founder of consultancy Bell Mason Group.
Mason considered Taranto’s success to be a combination of the right time and right place. He was already in the healthcare industry and came from pharmaceutical firm Johnson & Johnson to help Merck set up GHI in 2010.
However, Taranto told attendees at the Global Corporate…
